scholarly article | Q13442814 |
P50 | author | Paola Sebastiani | Q7132103 |
Martin H Steinberg | Q37380250 | ||
Lindsay A. Farrer | Q37380266 | ||
Heather L Edward | Q58179715 | ||
P2093 | author name string | S Wang | |
J J Farrell | |||
C T Baldwin | |||
P K Patra | |||
H Bae | |||
A K Al-Ali | |||
H Shappell | |||
D Ngo | |||
A Alsultan | |||
A Alsuliman | |||
A M Al-Rubaish | |||
D H K Chui | |||
F Al-Muhanna | |||
J N Milton | |||
V Vathipadiekal | |||
Z Naserullah | |||
P2860 | cites work | Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia | Q24652468 |
Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster | Q33706399 | ||
Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign. | Q33888761 | ||
Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients | Q34165031 | ||
Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype | Q34610322 | ||
A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. | Q34674466 | ||
Ancestry of African Americans with sickle cell disease | Q35049741 | ||
A functional element necessary for fetal hemoglobin silencing | Q35217485 | ||
Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes | Q35558802 | ||
Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans. | Q35827878 | ||
Genetic modifiers of sickle cell disease | Q36035471 | ||
Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations | Q36333394 | ||
DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease | Q36800496 | ||
Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation | Q37088889 | ||
Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing | Q37102932 | ||
Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S | Q37314123 | ||
An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. | Q39081873 | ||
Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. | Q39908659 | ||
Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects | Q40108760 | ||
The cooperative study of sickle cell disease: review of study design and objectives. | Q40343580 | ||
Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. | Q40591317 | ||
BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies | Q41827242 | ||
Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans | Q42322732 | ||
A functional promoter polymorphism of the δ-globin gene is a specific marker of the Arab-Indian haplotype | Q44362006 | ||
Fetal hemoglobin in sickle cell anemia: Saudi patients from the Southwestern province have similar HBB haplotypes but higher HbF levels than African Americans | Q46327662 | ||
The hematologic characteristics of sickle cell anemia bearing the Bantu haplotype: the relationship between G gamma and HbF level | Q46384824 | ||
Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type | Q46597587 | ||
Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of the tribal populations of India | Q46837730 | ||
Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous | Q47724047 | ||
Amplification-refractory mutation system (ARMS) analysis of point mutations. | Q54535992 | ||
cMYB is involved in the regulation of fetal hemoglobin production in adults. | Q54591078 | ||
Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia | Q67447872 | ||
Variable phenotypes of sickle cell disease in India with the Arab-Indian haplotype | Q87611221 | ||
Benign sickle-cell anaemia | Q93730107 | ||
P433 | issue | 3 | |
P921 | main subject | sickle-cell disease | Q185034 |
P304 | page(s) | 224-230 | |
P577 | publication date | 2015-01-30 | |
P1433 | published in | Blood Cells, Molecules and Diseases | Q15758051 |
P1476 | title | BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia | |
P478 | volume | 54 |
Q42711553 | A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia |
Q36191670 | Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions |
Q90619256 | BCL11A rs1427407 Genotypes in Sickle Cell Anemia Patients Undergo to Stroke Problems in Sudan |
Q88101760 | Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea |
Q97542138 | Combinatorial and statistical prediction of gene expression from haplotype sequence |
Q47147613 | Concise Review: Epigenetic Regulation of Hematopoiesis: Biological Insights and Therapeutic Applications |
Q38253721 | Demystifying the secret mission of enhancers: linking distal regulatory elements to target genes |
Q41957583 | Existence of HbF Enhancer Haplotypes at HBS1L-MYB Intergenic Region in Transfusion-Dependent Saudi β-Thalassemia Patients. |
Q39453785 | Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents |
Q51080070 | Genetic Variants at BCL11A and HBS1L-MYB loci Influence Hb F Levels in Chinese Zhuang β-Thalassemia Intermedia Patients. |
Q26799214 | Genomic approaches to identifying targets for treating β hemoglobinopathies |
Q41959356 | Homozygosity for a haplotype in the HBG2-OR51B4 region is exclusive to Arab-Indian haplotype sickle cell anemia |
Q37107201 | Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease |
Q45874809 | Pharmacological and molecular approaches for the treatment of β-hemoglobin disorders. |
Q40278751 | Protective BCL11A and HBS1L-MYB polymorphisms in a cohort of 102 Congolese patients suffering from sickle cell anemia. |
Q35996218 | Pulmonary function indices in children with sickle cell anemia in Enugu, south-east Nigeria |
Q53174215 | Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci. |
Search more.